NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation ("Edwards Lifesciences") (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for […]

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / If you suffered a loss on your Symbotic Inc. (NASDAQ:SYM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/symbotic-lawsuit-submission-form?prid=103770&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)

LiquidX, the development studio and publisher behind Pixelmon’s rebirth, has rebranded to MON Co. Led by a team of key executives from top venture and gaming studios such as Ubisoft, Electronic Arts (EA), Streamline Studios, Riot Games, Sony, Activision, and Warner Media, MON Co. is the unification and evolution of LiquidX’s current ecosystem of ventures.

WASHINGTON, D.C. / ACCESSWIRE / September 19, 2024 / The world of tech startups is one of unparalleled innovation, disruption, and rapid growth. Entrepreneurs entering this space know that they are part of a dynamic ecosystem, where cutting-edge technologies like artificial intelligence, quantum computing, blockchain, and cybersecurity are shaping the future. However, alongside the excitement

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/moderna-lawsuit-submission-form?prid=103769&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / If you suffered a loss on your Ford Motor Company (NYSE:F) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ford-lawsuit-submission-form?prid=103768&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

DALLAS, Sept. 19, 2024 (GLOBE NEWSWIRE) — P10, Inc. (NYSE: PX) (the “Company”), a leading private markets solutions provider, will host an Investor Day in New York today, beginning at 8:30 a.m. Eastern Time. During the event, P10’s management team and strategy leadership will provide an in-depth presentation of the Company’s strategic vision, investment strategies,

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Under Armour, Inc. ("Under Armour, Inc.") (NYSE:UA) concerning possible violations of federal securities laws. Under Armour issued a press release on September 9, 2024, "announc[ing] an update to its Fiscal 2025 restructuring plan,

Welsh, Carson, Anderson &Stowe (“WCAS” or the “Firm”), a leading private equity firm focused exclusively on the technology and healthcare industries, announced today that Jennifer Martin has joined the Firm as Chief Financial Officer and General Partner. Ms. Martin joins WCAS from Providence Equity Partners, where she was the Chief Financial Officer. https://mma.prnewswire.com/media/2508883/Welsh_Carson_Anderson_Stowe___Jennifer_Martin___CFO_and_General_Partner.jpg Ms. Martin

PleoPharma, Inc., a privately held company focused on cannabis related health issues, announced today that their CEO, Ginger Constantine, MD, presented at the Life Sciences PA’s Life Sciences Future Conference. https://mma.prnewswire.com/media/2497000/PleoPharma_Logo.jpg Dr. Constantine presented data from PleoPharma’s Phase 1 and Phase 2b studies of PP-01, their lead drug candidate intended for the mitigation of Cannabis